Leerink Partnrs Has Bullish Forecast for JANX Q2 Earnings
Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Equities researchers at Leerink Partnrs boosted their Q2 2025 earnings estimates for shares of Janux Therapeutics in a note issued to investors on Monday, May 12th. Leerink Partnrs analyst J. La. Rosa now expects that the company will post earnings per share of ($0.47) for the quarter, […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Equities researchers at Leerink Partnrs boosted their Q2 2025 earnings estimates for shares of Janux Therapeutics in a note issued to investors on Monday, May 12th. Leerink Partnrs analyst J. La. Rosa now expects that the company will post earnings per share of ($0.47) for the quarter, […]
